Literature DB >> 32633858

Psychological interventions for psychosis in adolescents.

Soumitra S Datta1,2, Rhea Daruvala2, Ajit Kumar3.   

Abstract

BACKGROUND: Psychosis is an illness characterised by alterations in thoughts and perceptions resulting in delusions and hallucinations. Psychosis is rare in adolescents but can have serious consequences. Antipsychotic medications are the mainstay treatment, and have been shown to be effective. However, there is emerging evidence on psychological interventions such as cognitive remediation therapy, psycho-education, family therapy and group psychotherapy that may be useful for adolescents with psychosis.
OBJECTIVES: To assess the effects of various psychological interventions for adolescents with psychosis. SEARCH
METHODS: We searched the Cochrane Schizophrenia Group's study-based Register of Trials including clinical trials registries (latest, 8 March 2019). SELECTION CRITERIA: All randomised controlled trials comparing various psychological interventions with treatment-as-usual or other psychological treatments for adolescents with psychosis. For analyses, we included trials meeting our inclusion criteria and reporting useable data. DATA COLLECTION AND ANALYSIS: We independently and reliably screened studies and we assessed risk of bias of the included studies. For dichotomous data, we calculated risk ratios (RRs) and 95% confidence intervals (CIs) on an intention-to-treat basis. For continuous data, we used mean differences (MDs) and the 95% CIs. We used a random-effects model for analyses. We created a 'Summary of findings' table using GRADE. MAIN
RESULTS: The current review includes 7 studies (n = 319) assessing a heterogenous group of psychological interventions with variable risk of bias. Adverse events were not reported by any of the studies. None of the studies was sponsored by industry. Below, we summarise the main results from four of six comparisons, and the certainty of these results (based on GRADE). All scale scores are average endpoint scores. Cognitive Remediation Therapy (CRT) + Treatment-as-Usual (TAU) versus TAU Two studies compared adding CRT to participants' TAU with TAU alone. Global state (CGAS, high = good) was reported by one study. There was no clear difference between treatment groups (MD -4.90, 95% CI -11.05 to 1.25; participants = 50; studies = 1, very low-certainty). Mental state (PANSS, high = poor) was reported by one study. Scores were clearly lower in the TAU group (MD 8.30, 95% CI 0.46 to 16.14; participants = 50; studies = 1; very low-certainty). Clearly more participants in the CRT group showed improvement in cognitive functioning (Memory digit span test) compared to numbers showing improvement in the TAU group (1 study, n = 31, RR 0.58, 95% CI 0.37 to 0.89; very low-certainty). For global functioning (VABS, high = good), our analysis of reported scores showed no clear difference between treatment groups (MD 5.90, 95% CI -3.03 to 14.83; participants = 50; studies = 1; very low-certainty). The number of participants leaving the study early from each group was similar (RR 0.93, 95% CI 0.32 to 2.71; participants = 91; studies = 2; low-certainty). Group Psychosocial Therapy (GPT) + TAU versus TAU One study assessed the effects of adding GPT to participants' usual medication. Global state scores (CGAS, high = good) were clearly higher in the GPT group (MD 5.10, 95% CI 1.35 to 8.85; participants = 56; studies = 1; very low-certainty) but there was little or no clear difference between groups for mental state scores (PANSS, high = poor, MD -4.10, 95% CI -8.28 to 0.08; participants = 56; studies = 1, very low-certainty) and no clear difference between groups for numbers of participants leaving the study early (RR 0.43, 95% CI 0.15 to 1.28; participants = 56; studies = 1; very low-certainty). Cognitive Remediation Programme (CRP) + Psychoeducational Treatment Programme (PTP) versus PTP One study assessed the effects of combining two types psychological interventions (CRP + PTP) with PTP alone. Global state scores (GAS, high = good) were not clearly different (MD 1.60, 95% CI -6.48 to 9.68; participants = 25; studies = 1; very low-certainty), as were mental state scores (BPRS total, high = poor, MD -5.40, 95% CI -16.42 to 5.62; participants = 24; studies = 1; very low-certainty), and cognitive functioning scores (SPAN-12, high = good, MD 2.40, 95% CI -2.67 to 7.47; participants = 25; studies = 1; very low-certainty). Psychoeducational (PE) + Multifamily Treatment (MFT) Versus Nonstructured Group Therapy (NSGT, all long-term) One study compared (PE + MFT) with NSGT. Analysis of reported global state scores (CGAS, high = good, MD 3.38, 95% CI -4.87 to 11.63; participants = 49; studies = 1; very low-certainty) and mental state scores (PANSS total, high = poor, MD -8.23, 95% CI -17.51 to 1.05; participants = 49; studies = 1; very low-certainty) showed no clear differences. The number of participants needing hospital admission (RR 0.84, 95% CI 0.36 to 1.96; participants = 49; studies = 1) and the number of participants leaving the study early from each group were also similar (RR 0.52, 95% CI 0.10 to 2.60; participants = 55; studies = 1; low-certainty). AUTHORS'
CONCLUSIONS: Most of our estimates of effect for our main outcomes are equivocal. An effect is suggested for only four outcomes in the SOF tables presented. Compared to TAU, CRT may have a positive effect on cognitive functioning, however the same study reports data suggesting TAU may have positive effect on mental state. Another study comparing GPT with TAU reports data suggesting GPT may have a positive effect on global state. However, the estimate of effects for all the main outcomes in our review should be viewed with considerable caution as they are based on data from a small number of studies with variable risk of bias. Further data could change these results and larger and better quality studies are needed before any firm conclusions regarding the effects of psychological interventions for adolescents with psychosis can be made.
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 32633858      PMCID: PMC7388907          DOI: 10.1002/14651858.CD009533.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  154 in total

1.  Preventing progression to first-episode psychosis in early initial prodromal states.

Authors:  A Bechdolf; M Wagner; S Ruhrmann; S Harrigan; V Putzfeld; R Pukrop; A Brockhaus-Dumke; J Berning; B Janssen; P Decker; R Bottlender; K Maurer; H-J Möller; W Gaebel; H Häfner; W Maier; J Klosterkötter
Journal:  Br J Psychiatry       Date:  2011-11-10       Impact factor: 9.319

2.  Examining interactions between risk factors for psychosis.

Authors:  Stanley Zammit; Glyn Lewis; Christina Dalman; Peter Allebeck
Journal:  Br J Psychiatry       Date:  2010-09       Impact factor: 9.319

3.  Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial.

Authors:  David J Miklowitz; Mary P O'Brien; Danielle A Schlosser; Jean Addington; Kristin A Candan; Catherine Marshall; Isabel Domingues; Barbara C Walsh; Jamie L Zinberg; Sandra D De Silva; Michelle Friedman-Yakoobian; Tyrone D Cannon
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-06-02       Impact factor: 8.829

4.  Coping as a predictor of treatment outcome in people at clinical high risk of psychosis.

Authors:  Mareike Kommescher; Michael Wagner; Verena Pützfeld; Julia Berning; Birgit Janssen; Petra Decker; Ronald Bottlender; Hans-Jürgen Möller; Wolfgang Gaebel; Wolfgang Maier; Joachim Klosterkötter; Andreas Bechdolf
Journal:  Early Interv Psychiatry       Date:  2014-02-25       Impact factor: 2.732

5.  [The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use].

Authors:  J P Boissel; M Cucherat; W Li; G Chatellier; F Gueyffier; M Buyse; F Boutitie; P Nony; M Haugh; G Mignot
Journal:  Therapie       Date:  1999 Jul Aug       Impact factor: 2.070

6.  Cost-effectiveness of intensive home treatment enhanced by inpatient treatment elements in child and adolescent psychiatry in Germany: A randomised trial.

Authors:  I Boege; N Corpus; R Schepker; R Kilian; J M Fegert
Journal:  Eur Psychiatry       Date:  2015-02-28       Impact factor: 5.361

7.  Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study.

Authors:  Jean A Frazier; Anthony J Giuliano; Jacqueline L Johnson; Lauren Yakutis; Eric A Youngstrom; David Breiger; Linmarie Sikich; Robert L Findling; Jon McClellan; Robert M Hamer; Benedetto Vitiello; Jeffrey A Lieberman; Stephen R Hooper
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-03-13       Impact factor: 8.829

8.  Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis.

Authors:  Lonneke van Nimwegen; Lieuwe de Haan; Nico van Beveren; Winfried Laan; Wim van den Brink; Don Linszen
Journal:  J Clin Psychopharmacol       Date:  2008-04       Impact factor: 3.153

9.  Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia.

Authors:  Til Wykes; Clare Reeder; Clare Williams; Julia Corner; Christopher Rice; Brian Everitt
Journal:  Schizophr Res       Date:  2003-06-01       Impact factor: 4.939

10.  Psychoeducational Group Intervention for Adolescents With Psychosis and Their Families: A Two-Year Follow-Up.

Authors:  Ana Calvo; Miguel Moreno; Ana Ruiz-Sancho; Marta Rapado-Castro; Carmen Moreno; Teresa Sánchez-Gutiérrez; Celso Arango; María Mayoral
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2015-10-13       Impact factor: 8.829

View more
  2 in total

1.  Quality of individual and group level interventions for first-episode psychosis at the tertiary psychiatric hospital in Uganda.

Authors:  Emmanuel K Mwesiga; Noeline Nakasujja; Lawrence Nankaba; Juliet Nakku; Seggane Musisi
Journal:  S Afr J Psychiatr       Date:  2021-04-22       Impact factor: 1.550

2.  Psychological Interventions for Young People With Psychotic Disorders: A Systematic Review.

Authors:  Vera Gergov; Branka Milic; Henriette Löffler-Stastka; Randi Ulberg; Eleni Vousoura; Stig Poulsen
Journal:  Front Psychiatry       Date:  2022-03-24       Impact factor: 5.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.